Replies to post #3868 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Another quotable quote from Bruce Carter, CEO of ZGEN:

“This will only go in one direction:
once someone switches to recombinant…
they will never go back [to plasma]”

From today’s ZGEN webcast announcing the thrombin deal with Bayer.